Monthly Archives: December 2015

FAQ on New Hep C Medicines

Access to new hepatitis C medicines in Australia – 22 December 2015 On 20 December 2015 Minister Ley made the very welcome announcement that funding had been allocated within the Mid -Year Economic and Fiscal Outlook (MYEFO) for the Pharmaceutical Benefits Scheme (PBS) listing of new hepatitis C treatments from 1 March 2016. Q. What […]

ACCESS TO CURE AN EARLY CHRISTMAS PRESENT FOR PEOPLE WITH HEPATITIS C

Hepatitis ACT Media Release: 20 December 2015 ACCESS TO CURE AN EARLY CHRISTMAS PRESENT FOR PEOPLE WITH HEPATITIS C Hepatitis ACT applauds Health Minister Sussan Ley and the Australian Government for listing highly effective new hepatitis C treatments on the Pharmaceutical Benefits Scheme. The new generation hepatitis C medicines have very high cure rates, short […]

Statement on access to new generation treatments for hepatitis C.

18 December 2015 Hepatitis Australia and our member organisations wish to express our sincere support for the thousands of Australians who are desperate to access the new hepatitis C medicines already available in other countries. The lack of access to these ground-breaking new treatments is simply unacceptable. We urge people to tell their story on […]

Innovation, Prime Minister? Yes Please!

Opinion Piece 1 December 2015 Published in: PharmaDispatch; Author: Helen Tyrell – CEO Hepatitis Australia Today should have been the day when Australia listed four of the most innovative medicines ever developed on the PBS for the benefit of Australians living with hepatitis C. But despite PBAC recommendations that date back to March, these breakthrough […]